In vivo 4-aminopyridine treatment alters the neurotoxin 3-acetylpyridine-induced plastic changes in intrinsic electrophysiological properties of rat cerebellar Purkinje neurones

European Journal of Pharmacology
Iran GoudarziMahyar Janahmadi

Abstract

Electrophysiological dysfunction of Purkinje cells causes cerebellar ataxia. Recent studies indicated that 4-aminopyridine (4-AP) can prevent the attacks in patients with episodic ataxia type 2. However, the cellular mechanism(s) by which 4-AP might be beneficial for the improvement of motor function remain unclear. Here, electrophysiological and behavioural consequences of in vivo co-treatment with 4-AP against 3-acetylpyridine (3-AP)-induced ataxia in rats were assessed. Combined treatment with 4-AP partially improved motor behaviour compared to the ataxic rats. Treatment with 3-AP alone induced plastic alterations in the cells' intrinsic properties, so that the latency of the initial neural spike was significantly increased (Pb 0.001); however, both instantaneous firing frequency and amplitude of calcium spikes were significantly (Pb 0.001) suppressed. 3-AP treatment also resulted in significant decrease in the duration of action potential (Pb 0.05) and the amplitude of afterhyperpolarization ((Pb 0.05) as well as post-stimulus hyperpolarization potentials (Pb 0.001). Purkinje cells in rats co-treated with 4-AP, however, fired predominantly in rhythmic bursts. The mean amplitude of Ca2+ spikes was significantly (Pb 0.001) gr...Continue Reading

References

Dec 19, 1975·Science·R LlinásC Sotelo
Apr 1, 1990·Annals of Neurology·C T BeverK P Johnson
Mar 1, 1988·Biological Psychiatry·M DavidsonK L Davis
Apr 1, 1985·Neurochemical Research·G E Gibson, J P Blass
Jan 1, 1980·Neuroscience·S Thesleff
Oct 1, 1984·Neuroscience Research·M ShimadaT Imahayashi
Aug 1, 1983·Journal of the Neurological Sciences·R E JonesR J Mason
Nov 1, 1994·Journal of Neurophysiology·J Flores-HernándezJ Bargas
Mar 1, 1996·Annals of Neurology·I Torres-AlemanJ Berciano
Mar 14, 1998·Proceedings of the National Academy of Sciences of the United States of America·A M FernandezI Torres-Aleman
Feb 4, 1999·Pflügers Archiv : European journal of physiology·Y Etzion, Y Grossman
Jul 22, 1999·Annals of the New York Academy of Sciences·W A CoetzeeB Rudy
Apr 13, 2000·The European Journal of Neuroscience·G D Muir, I Q Whishaw
Apr 20, 2001·Proceedings of the National Academy of Sciences of the United States of America·D Hess, A El Manira
Sep 3, 2002·The Journal of Physiology·Tiziana Sacco, Filippo Tempia
Feb 11, 2003·The Journal of Physiology·Jeremy R Edgerton, Peter H Reinhart
Jun 5, 2003·The Journal of Biological Chemistry·Inger LauritzenAmanda J Patel
Mar 30, 2004·Trends in Neurosciences·Paul D Dodson, Ian D Forsythe

❮ Previous
Next ❯

Citations

Dec 12, 2013·Computer Methods and Programs in Biomedicine·Samira AbbasiYashar Sarbaz
Mar 8, 2014·Toxicology and Industrial Health·Moazamehosadat RazavinasabMohammad Shabani
Oct 16, 2020·Neurodegenerative Disease Management·Laura De GiglioElena Maria Pennisi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxias (MDS)

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Ataxia

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Ataxias

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on different types of ataxias here.

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.